Related Experiment Videos
Defensins and acne.
1Centre for Cutaneous Research, Barts and the London, Queen Mary's School of Medicine and Dentistry, University of London, 2 Newark Street, London E1 2AT, UK. m.p.philpott@qmul.ac.uk
Molecular Immunology
|October 22, 2003
Summary
Antimicrobial peptides human beta-defensin 1 (hBD1) and human beta-defensin 2 (hBD2) are upregulated in acne vulgaris lesions. This suggests beta-defensins play a role in the inflammatory skin disease.
Area of Science:
- Dermatology
- Immunology
- Molecular Biology
Background:
- Acne vulgaris is a common skin condition affecting the pilosebaceous unit.
- Key factors include hypercornification, increased sebum, and microbial flora abnormalities.
- The mechanisms driving acne inflammation remain unclear.
Purpose of the Study:
- To investigate the expression of human beta-defensin 1 (hBD1) and human beta-defensin 2 (hBD2) in acne lesions.
- To compare expression in healthy hair follicles versus acne-affected skin.
Main Methods:
- Examined hBD1 and hBD2 immunoreactivity in healthy and acne vulgaris skin biopsies.
- Analyzed expression in various acne lesions: comedones, papules, and pustules.
Main Results:
- Strong hBD1 and hBD2 expression found in healthy epidermis and hair follicle compartments.
- Upregulated hBD2 and hBD1 expression detected in acne lesions, especially pustules.
- No expression in the proximal follicle bulb.
Conclusions:
- Beta-defensins are expressed in the pilosebaceous unit and hair follicle.
- Upregulation in acne lesions suggests a role in the disease's pathogenesis.